SCHEMBL1012703

SCHEMBL1012703

CC(C)c1cc(N)no1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5783331 0.81
SCHEMBL5781626 0.78
SCHEMBL5784548 0.73
SCHEMBL5783216 0.72 OGA (0.30)
SCHEMBL85820 0.72 GRM5 (0.44)
SCHEMBL468941 0.72
SCHEMBL19228219 0.71 NPC1 (0.41)
SCHEMBL14425145 0.70
SCHEMBL18000492 0.70
SCHEMBL20843934 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376478-B1 PYRIDYLOXYINDOLES INHIBITORS OF VEGF-R2 AND USE THEREOF FOR TREATMENT OF DISEASE NOVARTIS AG (CH) 2017-04-19 EP claimed
CN-107602497-B Preparation method of 3-amino-5-alkylisoxazole 浦拉司科技(上海)有限责任公司 2020-05-22 CN disclosed
US-10053430-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORP. (US) 2018-08-21 US disclosed
EP-2268623-B9 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORP (US) 2018-02-28 EP disclosed
US-9868763-B2 Modulators of protease activated receptors THE UNIVERSITY OF QUEENSLAND (AU) 2018-01-16 US disclosed
US-9868763-B2 Modulators of protease activated receptors THE UNIVERSITY OF QUEENSLAND (AU) 2018-01-16 US disclosed
US-20170298029-A1 RAF KINASE MODULATOR COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2017-10-19 US disclosed
US-9730937-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2017-08-15 US disclosed
US-9730937-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2017-08-15 US disclosed
US-9701711-B2 Modulators of protease activated receptors THE UNIVERSITY OF QUEENSLAND (AU) 2017-07-11 US disclosed
WO-2009117080-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATON (US) 2009-09-24 WO disclosed
US-20080188556-A1 Water-Soluble Prodrugs of Florfenicol and its Analogs SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2008-08-07 US disclosed
US-20080188556-A1 Water-Soluble Prodrugs of Florfenicol and its Analogs SCHERING-PLOUGH ANIMAL HEALTH CORPORATION 2008-08-07 US disclosed
US-20080153906-A1 Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System INTERVET INC. 2008-06-26 US disclosed
US-20080153906-A1 Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System INTERVET INC. 2008-06-26 US disclosed
US-20080146640-A1 Water-Soluble Prodrugs of Chloramphenicol, Thiamphenicol, and Analogs Thereof SCHERING-PLOUGH LTD. (CH) 2008-06-19 US disclosed
US-20080146640-A1 Water-Soluble Prodrugs of Chloramphenicol, Thiamphenicol, and Analogs Thereof SCHERING-PLOUGH LTD. (CH) 2008-06-19 US disclosed
US-20070155799-A1 CARBONATES OF FENICOL ANTIBIOTICS INTERVET INC. 2007-07-05 US disclosed
US-20070155799-A1 CARBONATES OF FENICOL ANTIBIOTICS INTERVET INC. 2007-07-05 US disclosed
EP-0044185-A2 Imidazolidinone derivatives ELI LILLY AND COMPANY (US) 1982-01-20 EP disclosed